These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 35682963)

  • 1. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.
    Nevedomskaya E; Haendler B
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics sciences and precision medicine in prostate cancer.
    Medori MC; Micheletti C; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Calogero AE; Cannarella R; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):95-103. PubMed ID: 37994753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
    Gómez-Cebrián N; Poveda JL; Pineda-Lucena A; Puchades-Carrasco L
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
    Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
    Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics based artificial intelligence for cancer research.
    Li L; Sun M; Wang J; Wan S
    Adv Cancer Res; 2024; 163():303-356. PubMed ID: 39271266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine Approach in Prostate Cancer.
    Assadi M; Jokar N; Ghasemi M; Nabipour I; Gholamrezanezhad A; Ahmadzadehfar H
    Curr Pharm Des; 2020; 26(31):3783-3798. PubMed ID: 32067601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
    Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
    Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Multi-Omics Approaches for Molecular Breeding of Black Rot Resistance in
    Shaw RK; Shen Y; Wang J; Sheng X; Zhao Z; Yu H; Gu H
    Front Plant Sci; 2021; 12():742553. PubMed ID: 34938304
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease.
    Lin B; White JT; Lu W; Xie T; Utleg AG; Yan X; Yi EC; Shannon P; Khrebtukova I; Lange PH; Goodlett DR; Zhou D; Vasicek TJ; Hood L
    Cancer Res; 2005 Apr; 65(8):3081-91. PubMed ID: 15833837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer.
    Gonthier K; Poluri RTK; Audet-Walsh É
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105367. PubMed ID: 31051242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes.
    Ghaffari S; Hanson C; Schmidt RE; Bouchonville KJ; Offer SM; Sinha S
    Genome Biol; 2021 Jan; 22(1):19. PubMed ID: 33413550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Prostate Cancer Treatment and Drug Discovery.
    Nevedomskaya E; Baumgart SJ; Haendler B
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.
    Sun YV; Hu YJ
    Adv Genet; 2016; 93():147-90. PubMed ID: 26915271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.